Current therapy is ineffective for many persons suffering from mental illnesses. We think that psychedelic-assisted treatment may give new therapeutic choices to those in need. People suffering from these ailments may find the optimism they seek in the future of psychedelic medicine.
Mydecine is dedicated to being truthful and open while maintaining the highest standards.
With a culture of diversity and inclusion, we are committed to making medication-based therapies geographically and financially accessible to those in need.
When medical communities embrace and utilize psychedelic medicine as a method of therapy inside our present healthcare framework, we will have achieved success. As psychedelic medicine becomes a trusted, evidence-based treatment option, we must act as leaders to change the narrative.
We think continuous development should be applied to everything we do, from goods and processes to business connections and culture. We will keep moving forward with open and honest feedback from our shareholders, employees, providers and patients, medical and scientific partners, and the general public.